TNO-SUB

TNO (Netherlands Organisation for Applied Scientific Research) is a leading independent research organization that operates extensively within the life sciences, biotechnology, and pharmaceutical sectors. The organization provides contract research services (CRO) and develops proprietary technology platforms to accelerate drug development, focusing on areas such as predictive health, digital health, and personalized medicine. TNO is particularly recognized for its advanced 'i-screen' platform for microbiome research and its 'Microtracer' technology for human microdosing studies (Phase 0). By bridging the gap between fundamental research and commercial application, TNO supports global pharmaceutical companies in optimizing drug efficacy and safety profiles.